
Link Pharma Chem Ltd Valuation Shifts to Very Attractive Amid Mixed Performance
2026-05-08 08:00:15Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive grade despite ongoing challenges in profitability and market performance. This article analyses the recent changes in key valuation metrics, compares them with peer averages, and assesses the implications for investors amid a volatile market backdrop.
Read More
Link Pharma Chem Ltd Valuation Shifts to Attractive Amid Mixed Performance
2026-04-28 08:00:34Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. Despite a challenging financial performance, the stock’s price metrics relative to peers and historical averages suggest a nuanced investment case that warrants close examination.
Read MoreLink Pharma Chem Ltd Gains 7.42%: Valuation and Technical Shifts Drive Weekly Moves
2026-04-11 17:11:42Key Events This Week 6 Apr: Valuation shifts to very attractive amid market challenges 8 Apr: Stock surges 8.29% following valuation upgrade 9 Apr: Rating upgraded to Sell on improved technicals and valuation 10 Apr: Week closes at Rs.28.68, up 7.42% for the week Week OpenRs.26.70 Week CloseRs....
Read More
Link Pharma Chem Ltd Valuation Shifts to Very Attractive Amidst Market Challenges
2026-04-06 08:00:26Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating despite ongoing market headwinds and a challenging financial performance. This article analyses the recent changes in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, compares them with peer averages, and assesses the implications for investors amid a deteriorating stock price and sector dynamics.
Read More
Link Pharma Chem Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Underperformance
2026-04-02 08:20:46Link Pharma Chem Ltd, a micro-cap player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating as of 1 April 2026, reflecting deteriorating fundamentals, challenging valuation metrics, and weak technical indicators. Despite some positive quarterly financial results, the company’s long-term performance and financial health continue to raise concerns among investors and analysts alike.
Read MoreLink Pharma Chem Ltd’s Volatile Week: -0.84% Price Change Amid Mixed Signals
2026-03-29 11:01:00Key Events This Week 16 Mar: Stock hits 52-week low amid downtrend (Rs.23.40) 17 Mar: Further 52-week low recorded (Rs.21.86) 18 Mar: MarketsMOJO upgrades rating to Sell; stock rallies 12.03% (Rs.24.49) 19 Mar: Price retreats amid Sensex plunge (Rs.23.50) 20 Mar: Stock rebounds 5.79% to close week at Rs.24.86 Week OpenRs.25.07 ...
Read MoreLink Pharma Chem Ltd Falls 8.93%: Downgrade and Valuation Shift Shape Volatile Week
2026-03-28 16:04:29Key Events This Week Mar 23: Stock closes at Rs.24.70, down 0.64% amid Sensex plunge Mar 24: Downgrade to Strong Sell and valuation shift announced Mar 25: Sharp 3.29% decline on heavy volume Mar 27: Week ends with 6.17% drop to Rs.22.64 Week OpenRs.24.86 Week CloseRs.22.64<div class="sta...
Read More
Link Pharma Chem Ltd Valuation Shifts to Attractive Amidst Challenging Market Returns
2026-03-24 08:00:50Link Pharma Chem Ltd has witnessed a notable change in its valuation parameters, moving from a very attractive to an attractive price level, despite ongoing challenges in profitability and returns. This shift in price-to-earnings and price-to-book value ratios, when analysed against historical trends and peer comparisons, offers investors a nuanced perspective on the stock’s current market positioning within the commodity chemicals sector.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
23-May-2026 | Source : BSENewspaper Publication of Audited Financial Result of the Company for the Quarter and year ended 31st March 2026. Published on 23rd May 2026 in Business Standard (English Edition) and Loksatta (Gujarati Edition).
Non Applicability Of Regulations 23(9) Of SEBI (LODR) Regulations 2015 On Disclosure Of Related Party Transactions For The Half Year Ended On 31St March 2026.
21-May-2026 | Source : BSENon Applicability of Regulations 23(9) of SEBI (LODR) Regulations 2015 on Disclosure of Non Applicability of reporting of Related Party Transactions for the Half year ended on 31st March 2026.
Announcement under Regulation 30 (LODR)-Change in Management
21-May-2026 | Source : BSERe-appointment of Mr. Rishikesh S. Thakur as Managing Director of the Company for 3 years.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available